Tag: abrocitinib

Topical pimecrolimus use for atopic dermatitis not linked to malignancy

Abrocitinib is more effective than dupilumab for treatment of moderate-to-severe atopic dermatitis

byNeel Mistryand1 others

August 2, 2022

1. The co-primary endpoints at weeks 2 and 4 were significantly greater with abrocitinib than dupilumab. 2. Overall incidence of ...

#VisualAbstract New RCT (JADE TEEN) shows efficacy and safety of abrocitinib in combination with topical therapy in adolescents with moderate-to-severe atopic dermatitis

byKathleen Lau

August 26, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result